Lucia Lopez-Corral Selected Research

Hemorrhage

3/2013

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucia Lopez-Corral Research Topics

Disease

2	Neoplasms (Cancer) 09/2022 - 01/2020
1	Hematologic Diseases (Blood Diseases) 09/2022
1	Infections 09/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	COVID-19 10/2021
1	Multiple Myeloma 01/2020
1	Cardiotoxicity 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Bronchiolitis Obliterans Syndrome 04/2018
1	Hemorrhage 03/2013
1	Thrombosis (Thrombus) 03/2013
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2013
1	Hemorrhagic Cystitis 07/2009

Drug/Important Bio-Agent (IBA)

1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022
1	AntibodiesIBA 09/2022
1	Monoclonal AntibodiesIBA 09/2022
1	brexucabtagene autoleucelIBA 01/2022
1	AnthracyclinesIBA 01/2020
1	daratumumabIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 07/2009
1	Cidofovir (Vistide)FDA Link 07/2009

Therapy/Procedure

4	Hematopoietic Stem Cell Transplantation 10/2021 - 07/2009
3	Transplantation 10/2021 - 03/2013
2	Therapeutics 09/2022 - 01/2020
2	Stem Cell Transplantation 10/2021 - 01/2019
1	Cell Transplantation 10/2021
1	Homologous Transplantation 03/2013